In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...
Class of 2026 Cadets Boston Graf, Maksymilian Olszowka and Elizabeth “Ezra” Bardales labored on a capstone project, a ...
SALT LAKE CITY - Palladyne AI (NASDAQ:PDYN) announced today the issuance of U.S. Patent 12,517,525 B1 for its Bayesian Program Learning framework, marking the company’s second patent in four months.
Palladyne AI (NASDAQ: PDYN), a U.S.-based defense and industrial technology company commercializing embedded AI, collaborative autonomy, and advanced avionics for defense markets, today announced the ...
Duke will have a lethal defensive frontcourt next season.
Faces of 4D is a series from Student Affairs that explores the diverse and complex ways in which the DU community lives the ...
SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI (NASDAQ: PDYN), a U.S.-based defense and industrial technology company commercializing embedded AI, collaborative autonomy, and advanced avionics for ...
Advances in artificial intelligence promise to help chemical engineers discover complex new materials. These materials could ...
The Duke basketball program has just received its biggest news so far. In major breaking news, sophomore center Patrick ...
SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment. It causes epilepsy, intellectual ...